Reaction Details Report a problem with these data
Target
Anoctamin-2
Ligand
BDBM50503431
Substrate
n/a
Meas. Tech.
Inhibition of ANO1 Over ANO2
IC50
12400±50 nM
Citation
 Namkung, W; Kim, IY; Seo, Y; Kim, JH Pharmaceutical composition for ANO1 antagonist with anticancer activity US Patent  US11274074 Publication Date 3/15/2022 
Target
Name:
Anoctamin-2
Synonyms:
ANO2 | ANO2_HUMAN | Anoctamin-2 | C12orf3 | TMEM16B | Transmembrane protein 16B
Type:
PROTEIN
Mol. Mass.:
113968.03
Organism:
Homo sapiens
Description:
ChEMBL_117372
Residue:
1003
Sequence:
MATPGPRDIPLLPGSPRRLSPQAGSRGGQGPKHGQQCLKMPGPRAPGLQGGSNRDPGQPCGGESTRSSSVINNYLDANEPVSLEARLSRMHFHDSQRKVDYVLAYHYRKRGVHLAQGFPGHSLAIVSNGETGKEPHAGGPGDIELGPLDALEEERKEQREEFEHNLMEAGLELEKDLENKSQGSIFVRIHAPWQVLAREAEFLKIKVPTKKEMYEIKAGGSIAKKFSAALQKLSSHLQPRVPEHSNNKMKNLSYPFSREKMYLYNIQEKDTFFDNATRSRIVHEILKRTACSRANNTMGINSLIANNIYEAAYPLHDGEYDSPEDDMNDRKLLYQEWARYGVFYKFQPIDLIRKYFGEKIGLYFAWLGLYTSFLIPSSVIGVIVFLYGCATIEEDIPSREMCDQQNAFTMCPLCDKSCDYWNLSSACGTAQASHLFDNPATVFFSIFMALWATMFLENWKRLQMRLGYFWDLTGIEEEEERAQEHSRPEYETKVREKMLKESNQSAVQKLETNTTECGDEDDEDKLTWKDRFPGYLMNFASILFMIALTFSIVFGVIVYRITTAAALSLNKATRSNVRVTVTATAVIINLVVILILDEIYGAVAKWLTKIEVPKTEQTFEERLILKAFLLKFVNAYSPIFYVAFFKGRFVGRPGSYVYVFDGYRMEECAPGGCLMELCIQLSIIMLGKQLIQNNIFEIGVPKLKKLFRKLKDETEAGETDSAHSKHPEQWDLDYSLEPYTGLTPEYMEMIIQFGFVTLFVASFPLAPVFALLNNVIEVRLDAKKFVTELRRPDAVRTKDIGIWFDILSGIGKFSVISNAFVIAITSDFIPRLVYQYSYSHNGTLHGFVNHTLSFFNVSQLKEGTQPENSQFDQEVQFCRFKDYREPPWAPNPYEFSKQYWFILSARLAFVIIFQNLVMFLSVLVDWMIPDIPTDISDQIKKEKSLLVDFFLKEEHEKLKLMDEPALRSPGGGDRSRSRAASSAPSGQSQLGSMMSSGSQHTNV
  
Inhibitor
Name:
BDBM50503431
Synonyms:
CHEMBL4471568 | US11274074, Example 3 [Chemical Formula 7]
Type:
Small organic molecule
Emp. Form.:
C17H15ClN2O3
Mol. Mass.:
330.766
SMILES:
COc1ccccc1-c1nnc(COc2ccc(Cl)cc2C)o1
Structure:
Search PDB for entries with ligand similarity: